As naive NK cells were shown unable to eradicate neuroblastoma cells, we additionally used NK cells that were prior stimulated with IL-2 and IL-15 (Fig. S1), similar to NK cells used in cellular immunotherapy. This evidence concerns the gene IL15 and neuroblastoma.